Tata group's low cost Covid-19 test 'Feluda' gets govt nod for launch
4 years, 3 months ago

Tata group's low cost Covid-19 test 'Feluda' gets govt nod for launch

India Today  

The Tata group on Saturday received approval for the commercial launch of India's first CRISPR Covid-19 test, 'Feluda', by the Drugs Controller General of India. "The Tata CRISPR test, powered by CSIR-IGIB FELUDA, received regulatory approvals today from DCGI for commercial launch, as per ICMR guidelines, meeting high quality benchmarks with 96 per cent sensitivity and 98 per cent specificity for detecting novel coronavirus," the statement said. The Tata CRISPR test is the world's first diagnostic test to deploy a specially adapted Cas9 protein to successfully detect the virus causing COVID-19, it said. Commenting on the development, Girish Krishnamurthy, CEO, TATA Medical and Diagnostics Ltd said, "The approval for the Tata CRISPR test for COVID-19 will give a boost to the country's efforts in fighting the global pandemic. "The commercialisation of Tata CRISPR test reflects the tremendous R&D talent in the country which can collaborate to transform India's contributions to the global healthcare and scientific research world," he said.

India Covid Tata Csir Crispr Gets Govt Test Feluda  tata  test  feluda  crispr  covid19  technology  research  groups  statement  nod  virus  scientific  launch  low  gets  govt  csirigib

History of this topic

An epidemiologically sound testing strategy
2 years, 11 months ago

An epidemiologically sound testing strategy

The Hindu  

On January 10, 2022, the Indian Council of Medical Research released an Advisory on Purposive Testing Strategy for COVID-19 in India. The latest COVID-19 testing strategy replaces the previous advisory, released on September 4, 2020 and inter alia, had the provision of COVID-19 testing on demand for ‘all individuals who wish to get themselves tested’. India, following this approach, ramped …

Can Genetic Modification Technology CRISPR be Applied to Covid-19 diagnostics?
3 years, 4 months ago

Can Genetic Modification Technology CRISPR be Applied to Covid-19 diagnostics?

News 18  

US scientists have repurposed genetic modification technology CRISPR to identify antibodies in patient blood samples in a move that could inspire a new class of medical diagnostics, particularly in the treatment of Covid-19. The technology involves customisable collections of proteins which are attached to a variant of Cas9, the protein at the heart of CRISPR, that will bind to DNA …

Tata's Healthcare Arm Ties Up With CSIR for Covid-19 Testing Across Smaller Towns and Rural Areas
3 years, 6 months ago

Tata's Healthcare Arm Ties Up With CSIR for Covid-19 Testing Across Smaller Towns and Rural Areas

News 18  

Tata Group's healthcare arm on Friday announced a tie-up with Centre for Scientific and Industrial Research for Covid-19 testing in smaller cities and rural areas. Tata MD, the newly formed venture of Tata Group, and the apex scientific research organisation will ramp up the Covid-19 testing capacity across Tier II and III towns as well as rural areas across India, …

India's first mRNA Covid vaccine candidate gets nod to start phase 1 trials
4 years ago

India's first mRNA Covid vaccine candidate gets nod to start phase 1 trials

India Today  

The Drugs Controller General of India has given conditional approval for Phase 1 and 2 clinical trials of India's first mRNA Covid-19 vaccine candidate -- HGCO19 -- that is being developed by Gennova Biopharmaceuticals. The conditional approval for human clinical trials were given after the recommendation of India's Subject Expert Committee on Covid-19. The committee deliberated upon the proposal submitted …

Coronavirus test: Delhi to get Feluda paper strip test kit today
4 years, 1 month ago

Coronavirus test: Delhi to get Feluda paper strip test kit today

Live Mint  

A fast and cheap paper-based Covid-19 test, called Feluda, will be launched in the national capital on 19 November by the Tata group in collaboration with the Apollo group of hospitals, reports Hindustan Times. The first batch of Feluda paper strip test, which has been approved by the Drugs Controller General of India for use in the country, will only …

Coronavirus India lockdown Day 211 updates | October 23, 2020
4 years, 2 months ago

Coronavirus India lockdown Day 211 updates | October 23, 2020

The Hindu  

India reported 55,839 new coronavirus cases, with 78% recorded from 10 States and Union Territories. - PTI Telangana Covaxin Phase III trial from November Vaccine maker Bharat Biotech plans to conduct Phase III clinical trial for COVID-19 vaccine candidate Covaxin from November. - N. Ravi Kumar Goa Plasma therapy will continue in Goa due to good results: Rane The Goa …

Coronavirus | Feluda test to be commercially available by month-end: CSIR Director General
4 years, 2 months ago

Coronavirus | Feluda test to be commercially available by month-end: CSIR Director General

The Hindu  

The Feluda test, a coronavirus detection test developed by the Council of Scientific and Industrial Research and to be commercialised by Tata Sons, will be commercially available in laboratories this month. Compared to the RT-PCR test, it’s reportedly cheaper — about ₹500 per test compared to ₹1,200-₹1,600 for RT-PCR, according to current estimates though that would be known only once …

Detect coronavirus in just 5 min: Nobel Prize winner develops unique Covid test
4 years, 2 months ago

Detect coronavirus in just 5 min: Nobel Prize winner develops unique Covid test

India Today  

At a time when scientists across world are racing against time to find an effective vaccine against Covid-19, a team of researchers led by Nobel Prize winner Jennifer Doudna has developed a unique test that can detect the novel coronavirus infection in just 5 minutes. The study says that the researchers used CRISPR gene-editing tool to come up with the …

India's Feluda Covid-19 Test Cheaper, Faster Alternative to RT-PCR, Say Scientists
4 years, 2 months ago

India's Feluda Covid-19 Test Cheaper, Faster Alternative to RT-PCR, Say Scientists

News 18  

More accurate than a rapid antigen test and almost as quick, India’s CRISPR Feluda’ COVID-19 test that changes colour on detection of the SARS-CoV-2 virus could be a cheaper, faster and simpler alternative to an RT-PCR diagnosis, say scientists. The CRISPR Feluda test is the world’s first diagnostic test to deploy a specially adapted Cas9 protein, derived from Francisella novicida …

Feluda Is Back! This Time To Detect Covid-19 Infection; Tata CRISPR's Test Gets DCGI Approval For Commercial Launch
4 years, 3 months ago

Feluda Is Back! This Time To Detect Covid-19 Infection; Tata CRISPR's Test Gets DCGI Approval For Commercial Launch

ABP News  

'Feluda', the Tata CRISPR Covid-19 test, has been approved by the Drugs Controller General of India, the Council of Scientific and Industrial Research announced on Saturday.For the uninitiated, the name 'Feluda' has perhaps been chosen as the name also belongs to a popular Indian detective character on the lines of Sherlock Holmes, in stories written by legendary writer-filmmaker Satyajit Ray. …

India's First Paper-strip Covid-19 Test Named After Satyajit Ray's 'Feluda', All You Need to Know
4 years, 3 months ago

India's First Paper-strip Covid-19 Test Named After Satyajit Ray's 'Feluda', All You Need to Know

News 18  

In April 2020, when the coronavirus pandemic was still in the initial phases, a team led by two Bengali-origin scientists, Dr Souvik Maiti and Dr Debojyoti Chakraborty, at the Council of Scientific & Industrial Research’s Institute of Genomics and Integrative Biology in New Delhi, came up with a simple ‘strip-test’ to tell you if you have COVID-19, in minutes. The …

India surpasses US in global COVID-19 recoveries as tally exceeds 53 lakh; SII to begin phase III trials from Monday
4 years, 3 months ago

India surpasses US in global COVID-19 recoveries as tally exceeds 53 lakh; SII to begin phase III trials from Monday

Firstpost  

Apart from the Oxford candidate, two more vaccine candidates in India are in advanced stages of clinical trials, while four are in pre-clinical development stage India’s single-day recovery exceeded the number of new infections as nearly 96,000 people recuperated from the novel coronavirus, even as the total caseload went past 53 lakh, according to the Union Health Ministry data updated …

Drug Body Approves Commercial Launch of Low Cost Covid-19 Test 'Feluda'
4 years, 3 months ago

Drug Body Approves Commercial Launch of Low Cost Covid-19 Test 'Feluda'

News 18  

The Drugs Controller General of India has approved the commercial launch of ’Feluda’, the Tata CRISPR Covid-19 test, the Council of Scientific and Industrial Research said on Saturday. ”The Tata CRISPR test, powered by CSIR-IGIB FELUDA, received regulatory approvals today from DCGI for commercial launch, as per ICMR guidelines, meeting high quality benchmarks with 96 per cent sensitivity and 98 …

Tata group to launch India's first CRISPR coronavirus test 'Feluda'
4 years, 3 months ago

Tata group to launch India's first CRISPR coronavirus test 'Feluda'

India TV News  

Tata group has received approval from the Drug Controller General of India for the commercial launch of the country's first CRISPR coronavirus test 'Feluda', the Council of Scientific and Industrial Research said on Saturday. "The Tata CRISPR test, powered by CSIR-IGIB FELUDA, received regulatory approvals today from DCGI for commercial launch, as per ICMR guidelines, meeting high quality benchmarks with …

India's First 'Tata CRISPR' Covid-19 Test Gets Approval by DCGI for Commercial Launch
4 years, 3 months ago

India's First 'Tata CRISPR' Covid-19 Test Gets Approval by DCGI for Commercial Launch

News 18  

The Tata CRISPR test, powered by CSIR-IGIB, received regulatory approval on Saturday from the Drug Controller General of India for its commercial launch, meeting high-quality benchmark with 96 per cent sensitivity and 98 per cent specificity for detecting novel coronavirus. The Tata CRISPR test is the world’s first diagnostic test to deploy a specially adapted Cas9 protein to successfully detect …

India, Israel developing covid-19 rapid testing kits: Commander Yaniv Meirman
4 years, 4 months ago

India, Israel developing covid-19 rapid testing kits: Commander Yaniv Meirman

Live Mint  

NEW DELHI: India and Israel could soon be collaborating on mass production of some innovative tests kits to detect covid-19. The tests, including two saliva tests and a breathalyzer test, are currently being evaluated in four hospitals in New Delhi. It could mean that even one minute before boarding an aircraft, a test could tell whether a passenger is covid-19 …

COVID-19 vaccine in India: Government to set guidance document for trials of vaccines, treatment
4 years, 5 months ago

COVID-19 vaccine in India: Government to set guidance document for trials of vaccines, treatment

Firstpost  

No process in vaccine development trials will be skipped, but approvals to carry out multiple phases of trials parallelly may be given. “The guidance document outlines how to maintain rigour while also fast-tracking the process,” Swarup told the daily, adding that trials underway in India were “adaptive”. She added that no process in vaccine development trials would be skipped, but …

Discover Related